Concepedia

A. Jegannathen

AJ

8

Publications

849

Citations

8

H-Index

2010

Active since

Affiliations

The Christie NHS Foundation Trust(Current)

Cambridge University Hospitals NHS Foundation Trust

University Hospital Southampton NHS Foundation Trust

University of Manchester

University Hospitals of North Midlands NHS Trust

A. Jegannathen is an author at The Christie NHS Foundation Trust specializing in radiation oncology, medicine, and oncology.

ORCID

Top concepts

Publications per year

2010–2022

8

Publications

8

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

, , +7

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Helena Earl, Louise Hiller, Anne-Laure Vallier et al. · The Lancet · 2019 · 277 citations · Full text

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial

N. Bayman, W. Appel, Linda Ashcroft et al. · Journal of Clinical Oncology · 2019 · 65 citations · Full text

Striking lung cancer response to self-administration of cannabidiol: A case report and literature review

Josep Sulé‐Suso, Nick Watson, Daniel Gey van Pittius et al. · SAGE Open Medical Case Reports · 2019 · 34 citations · Full text

Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer

Thomas Bachelot, Paul Cottu, Sylvie Chabaud et al. · Journal of Clinical Oncology · 2022 · 29 citations · Full text

Rows per page

1–5 of 8